Urotronic
Manufacturing · Minnesota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2495 Xenium Ln N, Plymouth, Minnesota, 5...Phone Number
(763) 285-7496Website
www.urotronic.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Urotronic
Urotronic, Inc. specializes in developing innovative drug-coated balloons, particularly the Optilume product, which offers effective treatment solutions for urethral strictures and benign prostatic hyperplasia (BPH). Their products aim to provide sustained patency and long-term relief for patients, making them a significant advancement in interventional urology. Urotronic is now part of Laborie, further enhancing their capabilities in the medical field. The company targets healthcare professionals and patients seeking advanced treatment options in urology.Explore more
Urotronic Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Urotronic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Urotronic has new funding data
Check if Urotronic has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Urotronic launches new products
Check out if Urotronic is spiking on competitors!
Earning: See what the market has to say on Urotronic recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Urotronic
Click to see if Urotronic had a recent Job posting/layoffs
Urotronic, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Urotronic as Masked Content
Find 3 more new buyers
Compare Similar Companies to Urotronic
Compare insights from companies similar to Urotronic, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Urotronic is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Urotronic is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Urotronic.
Urotronic financials insights
Gather financial insights about Urotronic, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Urotronic Tech Stack
A closer look at the technologies used by Urotronic
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Mergers & Acquisitions (M&A)
Funding
Urotronic News & Media
Patricia Industries funds Laborie’s strategic acquisition of Urotronic
Laborie, a subsidiary within Patricia Industries, has entered an agreement to acquire the remaining 91 percent of Urotronic, a US medical technology company, including its OptilumeTM device for the treatment of benign prostatic hyperplasia (BPH). In 2020, Laborie entered into a strategic partnership with Urotronic, whereby Laborie acquired 9 percent of the company and two separate call options, one for OptilumeTM urethral strictures, and one for the acquisition of the remaining 91 percent of UroLaborie Medical Technologies Announces Agreement to Acquire Urotronic for up to $600 Million
Acquisition expands urology portfolio and demonstrates Laborie's commitment to providing proven, innovative solutions to physicians and patients globally MINNEAPOLIS, Sept. 6, 2023 /PRNewswire/ -- Laborie Medical Technologies, Inc. (Laborie), a leading diagnostic and therapeutic medical...Urotronic Announces Publication of Data in Journal of Urology from PINNACLE Clinical Trial Evaluating Optilume® BPH Catheter System's Effectiveness and Durability
Study demonstrates Optilume BPH treatment results in significant improvements immediately post procedure through one year; highest reported Qmax in BPH MIST trials MINNEAPOLIS, Aug. 30, 2023 /PRNewswire/ -- Urotronic, Inc., a Minnesota-based medical device company pioneering the...Urotronic Announces Completion of the World's First Optilume® BPH Catheter System Commercial Procedure in Toronto
Optilume BPH is expected to have a significant global impact in urology, offering a novel alternative treatment option for enlarged prostate MINNEAPOLIS, July 18, 2023 /PRNewswire/ -- Urotronic, Inc., a Minnesota-based medical device company pioneering the application of its drug-coated...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Urotronic
Sign Up For FreeTo access detailed company insights
Urotronic, Inc. specializes in developing innovative drug-coated balloons, particularly the Optilume product, which offers effective treatment solutions for urethral strictures and benign prostatic hyperplasia (BPH). Their products aim to provide sustained patency and long-term relief for patients, making them a significant advancement in intervent... Read More
